Lionco Pharmaceutical Group Co.,Ltd. Posted 195.7 Million Yuan Net Loss in 2022

Lionco Pharmaceutical Group Co.,Ltd. (灵康药业集团股份有限公司) (603669.SH) reported a net loss of 195.7 million yuan in 2022, reversing a net profit of 65.9 million yuan for the previous year.

Meanwhile, the company posted 289.3 million yuan in revenue, down 60.9% year-on-year.

At the end of the reporting period, it had 1.9 billion yuan in total assets and 720.3 million yuan in total liabilities, with a liability-to-asset ratio of 38.8%.